Natura &Co Holding S.A. develops, manufactures, distributes, and sells cosmetics, fragrances, and personal care products. The company offers products for women and men, including skin care products for face and body, hair care and treatment products, makeup, soaps, deodorants, shower, cosmetics, fragrances, bath, sunscreen, oral hygiene, and baby and child toiletries, as well as fashion jewelry, watches, apparel, footwear, accessories, gift and decorative products, housewares, travel kits and packages, entertainment and leisure products, children's products, and nutritional products. It markets its products under the Natura, Aesop, Avon, and The Body Shop brands through signature and department stores, e-commerce, direct selling, franchises, third-party online resellers, amenity accounts, and physical multibrand retailers primarily in Asia, North America, South America, Europe, the Middle East, Africa, and Oceania. Natura &Co Holding S.A. was founded in 1969 and is headquartered in São Paulo, Brazil.
IPO Year: 2020
Exchange: NYSE
Website: ri.naturaeco.com/en
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/19/2022 | $7.00 → $8.00 | Neutral → Overweight | JP Morgan |
| 3/9/2022 | $10.00 | Underweight → Neutral | JP Morgan |
Fiscal Year registered positive net cash of BRL 1.7 billionNet income reached BRL 3.0 billion, of which BRL 979 million will be distributed as dividends SÃO PAULO, March 12, 2024 /PRNewswire/ -- Natura &Co's (B3:NTCO3) 2023 financial results, released today, reflect the benefits of a strategy defined and implemented 18 months ago, to prioritize profitability and cash conversion versus revenue growth, integrate the Natura and Avon brands in Latin America, and divest non-core assets to deleverage and simplify its corporate structure. Natura &Co's 2023 consolidated net revenue reached BRL 26.7 billion in the year, up 3.5% vs 2022 in constant currency (CC) and down 8.5% year-on-year in Brazilia
JP Morgan upgraded Natura &Co from Neutral to Overweight and set a new price target of $8.00 from $7.00 previously
JP Morgan upgraded Natura &Co from Underweight to Neutral and set a new price target of $10.00
Jefferies initiated coverage of Natura &Co with a rating of Buy and set a new price target of $28.00
Kristof Neirynck will be promoted to CEO of Avon as of January 1st 2024 SÃO PAULO, Nov. 30, 2023 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) announces Kristof Neirynck, currently the Global Chief Marketing Officer and Managing Director for Western Europe, as the new CEO of Avon. After a landmark 25 years with the company, Angela Cretu will continue to support and contribute to the Avon business, as an advisor. Under Angela's leadership, Avon initiated a successful turnaround strategy, streamlining its operating model and radically simplifying its portfolio. Through a major transformation of the commercial model, R&D redesign, and technology modernization, Avon's traditional direct
SC 13G/A - Natura &Co Holding S.A. (0001776967) (Subject)
SC 13G - Natura &Co Holding S.A. (0001776967) (Subject)
SC 13G/A - Natura &Co Holding S.A. (0001776967) (Subject)
SC 13G/A - Natura &Co Holding S.A. (0001776967) (Subject)
SC 13G/A - Natura &Co Holding S.A. (0001776967) (Subject)
Strong performance of Natura Brand in Brazil combined with solid margin results from the Wave 2-implemented countries led to YoY profitability evolution and more than offset Avon International's margin contraction amid sales deleverage SÃO PAULO, May 14, 2024 /PRNewswire/ -- Natura &Co's (B3: NTCO3) first quarter 2024 financial results (Q1-24), released today, showed increased profitability driven by solid results from Natura &Co Latam, which is benefiting from the integration of Natura and Avon in the region (referred to as 'Wave 2'), coupled with richer country and brand mix. This more than offset the margin contraction at Avon International amid sales deleveraging. Natura &Co's consolidat
Fiscal Year registered positive net cash of BRL 1.7 billionNet income reached BRL 3.0 billion, of which BRL 979 million will be distributed as dividends SÃO PAULO, March 12, 2024 /PRNewswire/ -- Natura &Co's (B3:NTCO3) 2023 financial results, released today, reflect the benefits of a strategy defined and implemented 18 months ago, to prioritize profitability and cash conversion versus revenue growth, integrate the Natura and Avon brands in Latin America, and divest non-core assets to deleverage and simplify its corporate structure. Natura &Co's 2023 consolidated net revenue reached BRL 26.7 billion in the year, up 3.5% vs 2022 in constant currency (CC) and down 8.5% year-on-year in Brazilia
The potential move would support the group's strategy of simplifying operations, strengthening brand autonomy and unlocking shareholder value SÃO PAULO, Feb. 5, 2024 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) announces that its Board of Directors has authorized its management to assess a possible separation of Natura &Co Latam and Avon to unlock further shareholder value. A separation would result in two independent, publicly traded beauty companies (Natura and Avon), with unique business plans, independent governance, and management teams, better equipped to pursue more tailored strategies to drive long-term shareholder value: Natura: a leading beauty company with historically
The delisting of ADRs is the next step in the company's long-term strategy SÃO PAULO, 18 January 2024 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) announces that its Board of Directors has approved a plan to end the company's secondary listing of American Depositary Shares (ADSs) on the New York Stock Exchange (NYSE), while maintaining its primary listing of common shares on the B3 stock exchange in São Paulo. In line with the company's long-term strategic objectives of simplifying operations, Natura &Co has decided to discontinue its secondary listing on the NYSE, as the vast majority of Natura &Co trading activity is concentrated on the B3 stock exchange. The decreasing trading v
Kristof Neirynck will be promoted to CEO of Avon as of January 1st 2024 SÃO PAULO, Nov. 30, 2023 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) announces Kristof Neirynck, currently the Global Chief Marketing Officer and Managing Director for Western Europe, as the new CEO of Avon. After a landmark 25 years with the company, Angela Cretu will continue to support and contribute to the Avon business, as an advisor. Under Angela's leadership, Avon initiated a successful turnaround strategy, streamlining its operating model and radically simplifying its portfolio. Through a major transformation of the commercial model, R&D redesign, and technology modernization, Avon's traditional direct
A new step to focus on strategic priorities SÃO PAULO, Nov. 14, 2023 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) announces that it has reached agreement to sell The Body Shop to international private equity group Aurelius, marking a new step in the Group's strategy to simplify and refocus its operations. Under the transaction, Aurelius has signed an agreement to acquire The Body Shop for an enterprise value of GBP 207 million, including an earn-out of GBP 90 million. The price and the earn-out will be payable in up to five years after closing. The closing of the transaction is expected to occur by December 31, 2023, and is subject to customary regulatory approvals. Morgan Stanley s
Wave 2 of integration between Natura and Avon launched in Brazil with encouraging early results; Natura &Co returns to a positive net cash position thanks to proceeds from Aesop sale SÃO PAULO, Nov. 14, 2023 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) continued to improve its profit margins in the third quarter, while deleveraging its balance sheet thanks to the proceeds of the sale of Aesop, which closed on August 30th. Natura &Co's Q3 consolidated net revenue stood at R$ 7.5 billion, broadly stable at constant currency (-0.7% at CC and -10.5% in BRL), with the Natura brand posting strong growth in Brazil and Latin America. Gross margin grew by 310 bps vs Q3 of last year to 65.3%
US$2.58 billion transaction will strengthen the Group's balance sheet SÃO PAULO, Aug. 30, 2023 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) announces that it has completed the sale of Aesop to L'Oréal for a final enterprise value of US$2.58 billion after obtaining all customary regulatory approvals. The transaction, initially announced on April 3, 2023, will allow Natura &Co to strengthen its balance sheet and focus on its strategic priorities, notably accelerating the integration of the Natura and Avon brands in Latin America, further optimizing Avon International's footprint and continuing to strengthen The Body Shop's business. Fabio Barbosa, Chief Executive Officer of Natura &Co,
Strong growth by Natura Latam and improving fundamentals at Avon International; solid improvement of 430 bps in gross margin in the quarter SÃO PAULO, Aug. 14, 2023 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) posted another quarter of sales growth in constant currency in the second quarter of 2023, while also continuing to improve its profit margins. Natura &Co posted Q2 consolidated net revenue of R$ 7.8 billion, up 1.9% at constant currency (-4.1% in BRL), driven by solid constant currency (CC) growth at Natura &Co Latam. Gross margin was 65.4%, up 430 bps vs Q2-22, and adjusted EBITDA margin was 9.7%, up 230 bps vs the same period last year, reflecting improving margins at all t
Strong growth by Natura &Co Latam and Aesop; Avon International enters positive territory in Beauty category SÃO PAULO, May 8, 2023 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) posted a resilient performance in the first quarter of 2023, with sales growth in constant currency and an improvement in profit margins. Natura &Co posted Q1 consolidated net revenue of R$ 8 billion, up 3.4% at constant currency (-2.8% in BRL), driven by solid constant currency (CC) growth at Natura &Co Latam and Aesop. Gross margin was 67.7%, up 370 bps vs Q1-22, and adjusted EBITDA margin was 10.5%, up 330 bps vs the same period last year, reflecting improving margins at Natura &Co Latam and Avon Internatio
25 - Natura &Co Holding S.A. (0001776967) (Filer)
6-K - Natura &Co Holding S.A. (0001776967) (Filer)
6-K - Natura &Co Holding S.A. (0001776967) (Filer)
6-K - Natura &Co Holding S.A. (0001776967) (Filer)
6-K - Natura &Co Holding S.A. (0001776967) (Filer)
6-K - Natura &Co Holding S.A. (0001776967) (Filer)
6-K - Natura &Co Holding S.A. (0001776967) (Filer)
6-K - Natura &Co Holding S.A. (0001776967) (Filer)
6-K - Natura &Co Holding S.A. (0001776967) (Filer)
6-K - Natura &Co Holding S.A. (0001776967) (Filer)
A separation would result in two independent, publicly traded beauty companies (Natura and Avon), with unique business plans, independent governance, and management teams, better equipped to pursue more tailored strategies to drive long-term shareholder value:
The delisting of ADRs is the next step in the company's long-term strategySÃO PAULO, 18 January 2024 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) announces that its Board of Directors has approved a plan to end the company's secondary listing of American Depositary Shares (ADSs) on the New York Stock Exchange (NYSE), while maintaining its primary listing of common shares on the B3 stock exchange in São Paulo.In line with the company's long-term strategic objectives of simplifying operations, Natura &Co has decided to discontinue its secondary listing on the NYSE, as the vast majority of Natura &Co trading activity is concentrated on the B3 stock exchange. The decreasing trading volu
JP Morgan analyst Joseph Giordano maintains Natura &Co Holding (NYSE:NTCO) with a Overweight and lowers the price target from $9 to $7.
Gainers TScan Therapeutics, Inc. (NASDAQ:TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. ClearOne, Inc. (NASDAQ:CLRO) climbed 66.1% to $2.06 after the company announced a special one-time cash dividend of $1.00 per share of common stock, payable May 31 to shareholders of record on May 22, 2023. Ensysce Biosciences, Inc. (NASDAQ:ENSC) gained 52.8% to $5.26 after the company announced completion of PF614-MPAR-101, a clinical study examining its first pain medication with overdose protection, PF614-MPAR. Mobiquity Technologies, Inc. (NASDAQ:MOBQ) climbed 48.5% to $0.2302 after gaining around 7% on Monday
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. Novavax, Inc. (NASDAQ:NVAX) shares jumped 46.4% to $10.91 after the company reported mixed Q1 financial results and issued FY23 revenue guidance above estimates. Shengfeng Development Limited (NASDAQ:SFWL) surged 26.7% to $5.62. Voyager Therapeutics, Inc. (NASDAQ:VYGR) shares gained 22.1% to $10.15 after reporting a profit for the first quarter. Rover Group, Inc. (NASDAQ:ROVR) rose 18.8% to $4.80 following strong quarterly results. Palantir Technologies Inc. (NYSE:PLTR) surged 17.8% to $9.12 after the company reported strong Q1 results and sai
Natura &Co Holding (NYSE:NTCO) reported its Q1 earnings results on Tuesday, May 9, 2023 at 06:05 AM. Here's what investors need to know about the announcement. Earnings Natura &Co Holding missed estimated earnings by 350.0%, reporting an EPS of $-0.18 versus an estimate of $-0.04. Revenue was down $169.00 million from the same period last year. Past Earnings Performance Last quarter the company missed on EPS by $0.32 which was followed by a 15.74% drop in the share price the next day. To track all earnings releases for Natura &Co Holding visit their earnings calendar here. This article was generated by Benzinga's automated content engine and reviewed by an editor.